No abstract

The purpose of this study was the evaluation of the effectiveness in the improvement of the psychic and symptomatic stress-related disorders by means of radio-electric stimulation on some auricular refl ex points with a device named the radio-electric asymmetric conveyer (REAC). This study was conducted on 124 subjects with psychological distress symptoms that were assessed by the Symptomatic Check List-90 (SCL-90) pre-and post-intervention. After randomization, two groups were created: a group treated with effective REAC and a group that underwent the same treatment with disarmed REAC (the placebo group). There was a signifi cant reduction in SCL-90 scores in the treated group compared with the placebo group. The results of the psychometric tests showed that the subjects who underwent effective therapy showed a statistically signifi cant (p < 0.05) reduction in their level of stress and psychological disorders compared with the control group. The reduction of the levels of perceived stress and the reduction of the psychic and symptomatic stress-related disorders assessed by SCL-90 tests, obtained after one cycle of refl ex auricular protocol REAC treatment, showed that this treatment can be useful in the cure of psychological stress-related symptoms.

BackgroundThe aim of this double-blind randomized study is to test the efficacy of a radio electric stimulator device using an auricular reflex therapy protocol for stress-related symptoms.MethodsThe study has been carried out on 200 subjects (138 females, 62 males) that voluntarily came to our Institute declaring to "feel stressed".The participants were randomly allocated with a computerized procedure: 150 were treated with auricular therapeutic protocol with radio electric stimulator device (REAC) and 50 were treated with an inactivated, placebo REAC. Psychological stress was evaluated trough the self-administered questionnaire Psychological Stress Measure (PSM). Assessment data were collected at 2 time points: before the treatment (T0) and immediately after the therapy cycle of 18 sessions about 4 weeks later (T1).ResultsIn the group treated with REAC, the psychometric evaluation after the therapy's cycle showed a significant reduction of PSM total scores, from 107.8 ± 23,13 at T0 to 87.1 ± 16,21 at T1 (p < 0.5), while in the control group no significant variation in decreasing stress-related symptomatology has been noted (107.86 ± 25,80 at T0 and 106.32 ± 25,88 at T1 (p = NS).ConclusionsThe protocol of the auricular treatment with REAC seems to reduce the subjective perception of stress, as "psychometrically" demonstrated by the significant reduction in PSM test total score. This therapeutical procedure also provides a non invasive, not painful and very simple innovative approach to treat the widely diffused stress related disorders.Trial RegistrationThis trial has been registered in the Australian New Zealand Clinical Trials Registry (ANZCTR) with the number: ACTRN12607000529448

BackgroundThe aim of this study is to investigate the effects of a radio electric asymmetric treatment on psycho-physiological disorders (PPD). PPD are often stress related and are under the unconscious control of the patient and cannot be traced back to any serious physical disease. The brain stimulation treatment protocol used is called Neuro Psycho Physical Optimization (NPPO) with a Radio Electric Asymmetric Conveyer (REAC) device.MethodsPsychological stress and PPD were measured for a group of 888 subjects using the Psychological Stress Measure (PSM) test, a self-administered questionnaire. Data were collected immediately before and after the 4-weeks of REAC treatment cycle.ResultsThis study showed a significant reduction in scores measuring subjective perceptions of stress for subjects treated with a cycle of NPPO REAC treatment. At the end-point the number of subjects reporting symptoms of stress-related PPD on the PSM test was significantly reduced, whereas in the placebo group the difference was not significant.ConclusionA cycle of NPPO treatment with REAC was shown to reduce subjective perceptions of stress measured by the PSM test and in particular on PPD.Trial RegistrationThis trial has been registered in the Australian New Zealand Clinical Trials Registry (ANZCTR) with the number: ACTRN12607000463471.

PurposeThe aim of this study is to investigate the effects of neuropsychophysical optimization (NPPO) protocol treatment by radioelectric asymmetric conveyer (REAC) technology in the management of sense of stress and confusion (SSC); an analysis of a single cluster of the psychological stress measure (PSM) test.Patients and methodsThe PSM, a self-administered questionnaire, was used to measure psychological stress and SSC for a group of 888 subjects. Data were collected immediately prior to and following the 4-week REAC-NPPO treatment cycle.ResultsThis study demonstrates a significant reduction in scores measuring subjective perceptions of stress for subjects treated with one cycle of REAC-NPPO. At the end-point of the study, the number of treated subjects reporting symptoms of stress-related SSC on the PSM test was significantly reduced, whereas there was no difference in sham-treated subjects.ConclusionOne cycle of REAC-NPPO appears to reduce subjective perceptions of SSC measured by the PSM.Trial registrationThis trial has been registered in the Australian New Zealand Clinical Trials Registry as ACTRN12607000497404.